CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | BARLOW JAMES F Director | Option exercise | +3,131 | 13,131 | ||
| 2024-06-14 | BARLOW JAMES F Director | Option exercise · Deferred Stock Units | −3,131 | 0 | ||
| 2024-06-14 | BARLOW JAMES F Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-14 | FARRELL PETER C Director | Option exercise | +3,131 | 55,741 | ||
| 2024-06-14 | FARRELL PETER C Director | Option exercise · Deferred Stock Units | −3,131 | 0 | ||
| 2024-06-14 | FARRELL PETER C Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-12 | SASSINE ANDY Chief Financial Officer | Sale | −50,000 | $32.03 | $1.6M | 220,526 |
| 2024-06-05 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −114 | $45.00 | $5K | 447,334 |
| 2024-06-03 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −26,000 | $40.01 | $1.0M | 447,448 |
| 2024-03-25 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −17,435 | $35.02 | $611K | 473,448 |
| 2024-03-19 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −8,565 | $35.01 | $300K | 490,883 |
| 2023-12-15 | SASSINE ANDY Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2023-12-15 | Chivukula Pad Chief Scientific Officer & COO | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-12-15 | Kurata Lance Chief Legal Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2023-12-15 | Kummerfeld Keith C See Remarks | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-12-15 | Payne Joseph E President and CEO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-11-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $18.72 | $94K | 499,448 |
| 2023-10-02 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $25.61 | $128K | 504,448 |
| 2023-09-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $31.45 | $157K | 509,448 |
| 2023-08-15 | SASSINE ANDY Chief Financial Officer | Grant or award | +1,223 | $17.37 | $21K | 270,526 |
Page 3 of 9 · 178 trades